Product NDC: | 52747-900 |
Proprietary Name: | Tandem |
Non Proprietary Name: | Ferrous Fumarate and Polysacchride Iron Complex |
Active Ingredient(s): | 115.2; 162 mg/1; mg/1 & nbsp; Ferrous Fumarate and Polysacchride Iron Complex |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52747-900 |
Labeler Name: | US Pharmaceutical Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20060217 |
Package NDC: | 52747-900-90 |
Package Description: | 90 CAPSULE in 1 BLISTER PACK (52747-900-90) |
NDC Code | 52747-900-90 |
Proprietary Name | Tandem |
Package Description | 90 CAPSULE in 1 BLISTER PACK (52747-900-90) |
Product NDC | 52747-900 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ferrous Fumarate and Polysacchride Iron Complex |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20060217 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | US Pharmaceutical Corporation |
Substance Name | FERROUS ASPARTO GLYCINATE; FERROUS FUMARATE |
Strength Number | 115.2; 162 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes |